Sonja M. Kessler
Halle, NI 06120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
HyperTRIBE identifies hepatic IGF2BP2/IMP2 targets in vivo and links IMP2 to autophagy.
Journal: NAR molecular medicine
Published: March 19, 2026
Physicochemical and Biological Characterization of the TLR7 Agonist SZU-106.
Journal: Pharmaceutical research
Published: December 02, 2025
The insulin-like growth factor 2 mRNA-binding protein 2 affects tumor cell metabolism via mitochondrial transporter activity and lipid alterations.
Journal: Cell death discovery
Published: August 27, 2025
Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer.
Journal: Cancers
Published: March 27, 2025
Gene Editing and Small Molecule Inhibitors of the RNA Binding Protein IGF2BP2/IMP2 Show its Potential as an Anti-Cancer Drug Target.
Journal: Frontiers in bioscience (Landmark edition)
Published: July 24, 2023
RNA binding protein IGF2BP2 expression is induced by stress in the heart and mediates dilated cardiomyopathy.
Journal: Communications biology
Published: April 19, 2023
Alterations in the hepatocyte epigenetic landscape in steatosis.
Journal: Epigenetics & chromatin
Published: March 19, 2023
Synthesis and Evaluation of Novel Substituted N-Aryl 1,4-Dihydropyridines as Antituberculostatic Agents.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates))
Published: March 17, 2023
A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.
Journal: Molecular cancer
Published: March 03, 2023
Endotoxin Tolerance Acquisition and Altered Hepatic Fatty Acid Profile in Aged Mice.
Journal: Biology
Published: January 27, 2023
Editorial: Multi-target directed ligands for the treatment of cancer.
Journal: Frontiers in oncology
Published: June 28, 2022
First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy.
Journal: ACS chemical biology
Published: January 13, 2022
Last Updated: 09/26/2026